ipilimumabnivolumabipi+nivoccRCCRCCYale Institutional Review Boardrenal cell carcinomacancer
…K Assay; and 21 patients with advanced ccRCC being treated with ipilimumab and nivolumab (ipi+nivo), assessed pre-treatment and prior to c…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…K Assay; and 21 patients with advanced ccRCC being treated with ipilimumab and nivolumab (ipi+nivo), assessed pre-treatment and prior to c…